Literature DB >> 7427877

Immunologic reactivity and prognosis in breast cancer.

S E Krown, C M Pinsky, H J Wanebo, D W Braun, P P Wong, H F Oettgen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7427877     DOI： 10.1002/1097-0142(19801015)46:8<1746::aid-cncr2820460808>3.0.co;2-u

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  5 in total

1.  Evaluation of lymphocyte immunity in breast cancer patients.

Authors:  J F Head; R L Elliott; J L McCoy
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

2.  Long-term (5-11 years) follow-up of general immune competence in breast cancer. I. Pre-treatment levels with reference to micrometastasis.

Authors:  H S Shukla; L E Hughes; R H Whitehead; R G Newcombe
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

3.  Combination chemotherapy (VAC/FMC) with immunostimulation in metastatic breast cancer: a randomized study comparing different times and routes of administration of Corynebacterium parvum.

Authors:  D Fritze; B Massner; R Becher; M Kaufmann; H J Illiger; J Hartlapp; W Queisser; U Abel; L Edler; A C Mayr
Journal:  Klin Wochenschr       Date:  1984-02-15

4.  A randomized study of combination chemotherapy (VAC-FMC) with or without immunostimulation by Corynebacterium parvum in metastatic breast cancer.

Authors:  D Fritze; R Becher; B Massner; M Kaufmann; U Bruntsch; W M Gallmeier; A C Mayr; P Drings; U Abel; L Edler; W F Jungi; W Queisser; H J Senn
Journal:  Klin Wochenschr       Date:  1982-06-15

5.  Delayed-hypersensitivity skin testing and childhood cancer.

Authors:  M Munzarová; A Kubíková-Kourilová; V Kolcová
Journal:  Br J Cancer       Date:  1982-06       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.